1. Home
  2. WASH vs PHAR Comparison

WASH vs PHAR Comparison

Compare WASH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WASH
  • PHAR
  • Stock Information
  • Founded
  • WASH 1800
  • PHAR 1988
  • Country
  • WASH United States
  • PHAR Netherlands
  • Employees
  • WASH N/A
  • PHAR N/A
  • Industry
  • WASH Major Banks
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WASH Finance
  • PHAR Health Care
  • Exchange
  • WASH Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • WASH 542.9M
  • PHAR 731.1M
  • IPO Year
  • WASH N/A
  • PHAR N/A
  • Fundamental
  • Price
  • WASH $29.49
  • PHAR $10.00
  • Analyst Decision
  • WASH Buy
  • PHAR Strong Buy
  • Analyst Count
  • WASH 4
  • PHAR 3
  • Target Price
  • WASH $32.25
  • PHAR $30.00
  • AVG Volume (30 Days)
  • WASH 151.7K
  • PHAR 3.6K
  • Earning Date
  • WASH 07-21-2025
  • PHAR 07-31-2025
  • Dividend Yield
  • WASH 7.57%
  • PHAR N/A
  • EPS Growth
  • WASH N/A
  • PHAR N/A
  • EPS
  • WASH N/A
  • PHAR N/A
  • Revenue
  • WASH $110,088,000.00
  • PHAR $320,708,000.00
  • Revenue This Year
  • WASH $57.46
  • PHAR $13.31
  • Revenue Next Year
  • WASH $9.82
  • PHAR $7.68
  • P/E Ratio
  • WASH N/A
  • PHAR N/A
  • Revenue Growth
  • WASH N/A
  • PHAR 24.13
  • 52 Week Low
  • WASH $24.95
  • PHAR $6.65
  • 52 Week High
  • WASH $40.59
  • PHAR $12.61
  • Technical
  • Relative Strength Index (RSI)
  • WASH 61.71
  • PHAR 43.61
  • Support Level
  • WASH $29.27
  • PHAR $9.99
  • Resistance Level
  • WASH $30.15
  • PHAR $10.59
  • Average True Range (ATR)
  • WASH 0.67
  • PHAR 0.35
  • MACD
  • WASH 0.18
  • PHAR -0.14
  • Stochastic Oscillator
  • WASH 79.94
  • PHAR 7.45

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: